Skip to main content
Fig. 3 | BMC Musculoskeletal Disorders

Fig. 3

From: Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial

Fig. 3

Visual analogue scale 0-10 cm for overall pain, change from baseline. *p intragroup < 0.001 (all 3 groups); p < 0.001 between baseline and weeks 6, 12 and 24; p > 0.05 between weeks 6, 12 and 24. 95% Confidence Intervals: PRP – week 6 (-3.6; -1.2), week 12 (-4.8; -3.4), week 24 (-4.0; -1.7); Plasma – week 6 (-3.1; -1.2), week 12 (-4.0; -1.4), week 24 (-3.5; -1.3); Placebo – week 6 (-4.2; -2.0), week 12 (-4.0; -1.3), week 24 (-4.9; -2.1).

Back to article page